Diabetes MellitusNCT07881588
Construction and Empirical Research of a Risk Prediction Model for Preventing Lower Extremity Arteriosclerosis Obliterans in Diabetic Patients Based on the HAPA Model
A study testing Routine Care and Experimental group intervention in people with Diabetes Mellitus and Peripheral Arterial Disease, run by Second Affiliated Hospital of Nanchang University at 1 site in China.
Trial summary
In this study, Logistic regression analysis was used to construct a risk prediction model for ASO in diabetic patients. Guided by the HAPA model, a nursing intervention plan for preventing ASO in diabetic patients was constructed and verified, with the aim of reducing the occurrence of ASO in diabetic patients and… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Diabetes Mellitus, Peripheral Arterial Disease
- What is being tested?
- Routine Care and Experimental group intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 154 participants
- Where
- 1 siteChina
- Study dates
- 15 Apr 2025to 1 Dec 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Meet the clinical diagnostic criteria for type 2 diabetes;
- Age ≥18 years old;
- The patient is conscious, has no language communication barriers, and has certain reading and writing abilities.
- The patient or caregiver can use smart devices.
- Informed consent and voluntary participation.
Who cannot join
- Those with severe audio-visual or cognitive impairments;
- Combined with other serious physical diseases, such as malignant tumors, etc.
- Have a history of mental illness;
- Patients who already have lower extremity arterial disease.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site, 1 recruiting
- Recruiting
The Second Affiliated Hospital of Nanchang University
Nanchang, Jang XI, 330006
Chunyan Zheng, 18979136718, zhengchunyan120@163.com
About this study
In this study, Logistic regression analysis was used to construct a risk prediction model for ASO in diabetic patients. Guided by the HAPA model, a nursing intervention plan for preventing ASO in diabetic patients was constructed and verified, with the aim of reducing the occurrence of ASO in diabetic patients and providing a reference for improving the quality of life of diabetic patients in clinical practice
- Conditions
- Diabetes Mellitus, Peripheral Arterial Disease
- Being tested
- Routine Care, Experimental group intervention
- Medical subject headings
- Diabetes Mellitus, Peripheral Arterial Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Routine CareOther
Upon admission, the researcher and responsible nurse jointly assess the patient's condition, help the patient relax, introduce the hospital environment, ward routines, and relevant regulations, and the researcher guides the patient to complete the general information questionnaire. During hospitalization, the researcher first explains the causes and influencing factors of diabetes in a demonstration classroom, emphasizes healthy lifestyle habits, and advises smoking cessation and alcohol limitation. Next, dietary and exercise guidance is provided to both patients and their families. Finally, instruction is given on blood sugar monitoring and the importance of taking medication as prescribed.
Experimental group interventionBehavioural
Based on the control group, the experimental group implemented the ASO prevention and nursing intervention program for diabetic patients based on the risk prediction model and the HAPA model. The intervention was divided into four stages. The first stage was the pre-intention stage, in which face-to-face communication was adopted to improve patients' disease cognition. The second stage was the intention stage. This stage involves converting patients' behavioral intentions into practical actions through knowledge education, skill guidance, etc. The third stage is the action stage, where healthy behaviors are generated and maintained through providing social support, supervision and evaluation, etc.
| Study group | Role | What they receive |
|---|---|---|
| control group | Active comparator | The control group received routine care, namely admission education, routine care and education during hospitalization, unified health education at discharge, and routine follow-up after discharge. Receives: Other: Routine Care |
| Experimental group | Experimental | Based on the control group, the experimental group implemented the ASO prevention and nursing intervention program for diabetic patients based on the risk prediction model and the HAPA model Receives: Behavioral: Experimental group intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
ankle brachial index, ABI
Measured: Collected respectively before the intervention and at 1, 3, and 6 months after the intervention
Summary of Diabetes Self Care Activities, SDSCA
This scale is used to assess the self-management ability of diabetic patients. It consists of 12 items, each of which is calculated on an 8-point scale ranging from 0 to 7. Individuals choose a score of 0 to 7 based on the number of days they have implemented it. The higher the score, the better the self-management ability. A score of 80 or above indicates good self-management ability, 60 to 80 indicates medium self-management ability, and below 60 indicates poor self-management ability.
Measured: Collected respectively before the intervention and at 1, 3, and 6 months after the intervention
Secondary outcomes (2)
Diabetes Specific Quality of Life Scale, DSQL
DSQL is a specific quality of life scale designed for Chinese diabetic patients, consisting of 27 items in four dimensions: physiological, psychological, social and therapeutic. The total score ranges from 27 to 135 points. The higher the score, the worse the quality of life. The reference cut-off values are as follows: a score below 54 is considered good, 55 to 81 is medium, and a score above 82 indicates a poor quality of life. This scale has good reliability, validity and responsiveness, and is suitable for evaluating the current quality of life and intervention effects of Chinese diabetic patients.
Measured: Collected respectively before the intervention and at 1, 3, and 6 months after the intervention
The Third Version of Diabetes Attitude Scale, DAS-3
The DAS-3 scale consists of five dimensions: Professional training needs, severity of type 2 diabetes, the value of strict blood sugar control, psychosocial impact and patient autonomy were scored using a 5-point Likert scale (1= strongly disagree, 5= strongly agree). Among them, the reverse scoring items needed to be converted to 6 minus the original score. The final score of each dimension was the average score of all items processed under that dimension. The higher the score, the more positive the attitude and the more in line with modern diabetes management concepts
Measured: Collected respectively before the intervention and 1, 3, and 6 months after the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Oct 2026
- Study start15 Apr 2025
- Primary completion1 Oct 2027 (estimated)
- Study completion1 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diabetes MellitusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Sequential
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 154 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Second Affiliated Hospital of Nanchang University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07881588
- Sponsor's protocol ID
- IIT-I-2025-038
- Status last verified
- Aug 2026
- First submitted
- 11 Jun 2025
- Last updated
- 19 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No